Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Psoriasis Clinical Trials

102 recruiting trials for Psoriasis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
102
Total Trials
102
Recruiting Now
15
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT07289399

Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?

Women with psoriasis usually develop many complications including polysyctic ovarian syndrome (PCOS). Nowdays, diet restriction combimed with phsyical exercises may improve both...

Sponsor: Cairo UniversityEnrolling: 401 location
RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT04191395

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points....

Sponsor: Centre Hospitalier Universitaire de BesanconEnrolling: 30001 location
RECRUITINGNCT02103361

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic...

Sponsor: University of California, San DiegoEnrolling: 2001 location
RECRUITINGNCT04751396

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for...

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 1251 location
RECRUITINGNCT07270003

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the...

What's the problem? Palmoplantar pustulosis (PPP) is a long-term skin condition that mainly affects the palms of hands and soles of feet. It causes red, scaly skin with small,...

Sponsor: Xijing HospitalEnrolling: 601 location
RECRUITINGNCT07277491

Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

The aim of the present work is to assess the nutritional status among different rheumatic diseases patients and to study its association with the corresponding diseases activity.

Sponsor: Cairo UniversityEnrolling: 4601 location
RECRUITINGPhase 3NCT07286058

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is...

Sponsor: TakedaEnrolling: 11821 location
RECRUITINGPhase 3NCT06671496

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well...

Sponsor: TakedaEnrolling: 60020 locations
RECRUITINGNCT07128472

Evaluation of IL 12B Genetic Polymorphism (rs3213094)

Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with...

Sponsor: South Valley UniversityEnrolling: 401 location
RECRUITINGNCT07039110

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe...

Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. This study will assess the change...

Sponsor: AbbVieEnrolling: 70020 locations
RECRUITINGNCT07180537

Creating Health Course Study for People With Rheumatological Conditions

The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological...

Sponsor: Terry L. WahlsEnrolling: 2001 location
RECRUITINGPhase 3NCT06648772

Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

This study is a multi-center, randomized, double-blind, vehicle-controlled phase III study to evaluate the efficacy, safety, and PK profile of roflumilast cream 0.3% in Chinese...

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Enrolling: 18920 locations
RECRUITINGPhase 2NCT04924270

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

PURPOSE: The main purpose is to explore clinical efficacy and safety associated with capsule FMT (cFMT) performed in newly diagnosed, untreated patients with rheumatic and...

Sponsor: Odense University HospitalEnrolling: 2001 location
RECRUITINGNCT06448689

Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis

Pruritis is a common symptom in patients with atopic dermatitis and psoriasis. Patients with atopic dermatitis and psoriasis often report pruritis-associated sleep impairments and...

Sponsor: ActiGraph L.L.CEnrolling: 901 location
RECRUITINGNCT06258668

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis...

The purpose of this observational study is to describe the safety and effectiveness of deucravacitinib in participants in Korea that have been diagnosed with moderate-to-severe...

Sponsor: Bristol-Myers SquibbEnrolling: 5052 locations
RECRUITINGPhase 3NCT07265284

A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

The purpose of this study is to evaluate the efficacy and safety of IBI112 in the treatment of adolescent participants with moderate to severe plaque-type psoriasis.

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Enrolling: 1041 location
RECRUITINGNCT06382987

A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)

This is a prospective, observational, real-world study of adult participants in Japan with physician-reported diagnosis of plaque psoriasis treated with deucravacitinib or...

Sponsor: Bristol-Myers SquibbEnrolling: 6002 locations
RECRUITINGPhase 4NCT07503652

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Palmoplantar pustulosis (PPP) is a chronic and recurrent skin disease, mainly characterized by erythema, pustules and scales on the palms and soles, often accompanied by itching...

Sponsor: First Hospital of China Medical UniversityEnrolling: 101 location
RECRUITINGNCT06586281

Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

While many studies examine Nonalcoholic fatty liver disease (NAFLD), little is known about its progression to high-risk nonalcoholic steatohepatitis (NASH) in PsA patients. Shared...

Sponsor: University of California, San DiegoEnrolling: 201 location
RECRUITINGPhase 3NCT06979453

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants...

The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis

Sponsor: Bristol-Myers SquibbEnrolling: 36620 locations
RECRUITINGPhase 3NCT06477237

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

This is a multicenter, randomized, double-blind, placebo-controlled, phase III clinical study which is designed to determine the efficacy, safety, immunogenicity and...

Sponsor: Huabo Biopharm Co., Ltd.Enrolling: 40020 locations
RECRUITINGPhase 3NCT07130604

Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

This study is a randomized, double-blind, placebo-controlled multicenter clinical trial targeting subjects with moderate to severe plaque psoriasis.

Sponsor: InventisBio Co., LtdEnrolling: 3901 location
RECRUITINGNCT03248284

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Tendon pathologies (enthesitis) are a characteristic component of psoriatic arthritis (PsA), and are observed in 35% to 50% of PsA patients. The Achilles tendon is one of the most...

Sponsor: Odense University HospitalEnrolling: 302 locations
RECRUITINGNCT07250997

PALLAS Laser for Skin Diseases

The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis,...

Sponsor: Szeged UniversityEnrolling: 501 location
RECRUITINGPhase 2NCT07314060

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study, all subjects need to use TQH2929 injection/placebo. The aim was to demonstrate the...

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrolling: 3620 locations
RECRUITINGNCT07011979

SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease

The goal of this observational study is to investigate characteristics of individuals at high risk for developing Inflammatory Bowel Disease (IBD) in order to identify risk...

Sponsor: Seoul National University HospitalEnrolling: 5001 location
RECRUITINGNCT07183423

Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction

The goal of this clinical trial is to learn if a novel barrier topical product works to treat barrier dysfunction in adults. It will also learn about the safety of the novel...

Sponsor: Makati Medical CenterEnrolling: 261 location
RECRUITINGNCT04359394

International Rare And Severe Psoriasis Expert Network

This registry is a prospective observational study in order to describe primarily the natural course of PP subtypes and to gain detailed information about their phenotype.

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 1808 locations
RECRUITINGNCT06498167

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

The LOOK-UP is an investigator-initiated clinical study with the aim of monitoring the post-marketing safety of the medicine Rinvoq™ (upadacitinib), which is indicated for the...

Sponsor: Universidade do PortoEnrolling: 1503 locations
RECRUITINGNCT05954364

Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis

Sex and gender are important factors that influence treatment response in PsA. The goal of this multi-centre observational study is to understand how sex and gender influence...

Sponsor: Women's College HospitalEnrolling: 5401 location
RECRUITINGNCT06574178

Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After...

Psoriasis is a chronic inflammatory disease that affects the skin and joints in 2-3 % of people in the United States. This inflammation of the skin, joints, and blood vessels in...

Sponsor: University of California, DavisEnrolling: 51 location
RECRUITINGPhase 2NCT06058546

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).

Sponsor: Tasly Pharmaceutical Group Co., LtdEnrolling: 18012 locations
RECRUITINGPhase 3NCT04772079

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to...

The purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of Deucravacitinib in pediatric participants aged 4 to \<18 years with moderate to severe...

Sponsor: Bristol-Myers SquibbEnrolling: 15320 locations
RECRUITINGNCT04110522

Psoriatic Arthritis D2P Screening

The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis....

Sponsor: Jessica WalshEnrolling: 180002 locations
RECRUITINGNCT05621369

Psorcast Mobile Study

The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an...

Sponsor: Sage BionetworksEnrolling: 10001 location
RECRUITINGNCT04170244

Skin Microbial Ecology in Atopic Dermatitis

Everybody's skin has bacteria that normally lives on it. Previous research has shown that people with eczema (or atopic dermatitis \[AD\]) have much higher concentrations of a...

Sponsor: University of RochesterEnrolling: 2401 location
RECRUITINGPhase 3NCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

Sponsor: Bristol-Myers SquibbEnrolling: 304020 locations
RECRUITINGPhase 4NCT05858645

Correction of Psoriatic T Cell Signatures by Deucravacitinib

This study aims to assess cutaneous and blood immune cell function of patients with psoriasis before and after initiation of treatment with the Tyrosine kinase 2 (TYK2) blocker,...

Sponsor: University of California, San FranciscoEnrolling: 251 location
RECRUITINGPhase 3NCT06671483

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well...

Sponsor: TakedaEnrolling: 108820 locations
RECRUITINGPhase 3NCT07250802

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

The main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with moderate-to-severe plaque...

Sponsor: TakedaEnrolling: 11020 locations
RECRUITINGPhase 2NCT07148414

A Study of SPY072 in Rheumatic Disease

This is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 compared to placebo...

Sponsor: Spyre Therapeutics, Inc.Enrolling: 28520 locations
RECRUITINGPhase 2 / Phase 3NCT06477536

Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

This is a Phase IIb, long term extension study to evaluate the safety and efficacy of HB0034 in adult subjects with generalized pustular psoriasis (GPP).

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.Enrolling: 333 locations
RECRUITINGPhase 1NCT07258745

Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With...

This is a Phase 1, first-in-human (FIH), randomized, double-blind, single-dose, parallel-group, 3-arm study to compare PK, safety, tolerability, and immunogenicity profiles of...

Sponsor: Chong Kun Dang PharmaceuticalEnrolling: 2131 location
RECRUITINGPhase 2NCT06912165

A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Th purpose of the study is to evaluate the dose response of WD-890 in efficacy at Week 16 in participants with moderate-to-severe plaque psoriasis.

Sponsor: Zhejiang Wenda Pharma Technology LTD.Enrolling: 1401 location
RECRUITINGPhase 2NCT07194200

Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial

A growing body of evidence indicates that the pathogenesis of psoriasis may be closely linked to skin microbiome dysbiosis. Compared with healthy individuals, the composition and...

Sponsor: Shenzhen People's HospitalEnrolling: 1841 location
RECRUITINGNCT06870500

Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient

Psoriasis is a chronic, immune-mediated, multisystemic, inflammatory disease caused by the interaction of multiple susceptibility genes and environmental factors that affects 1-3%...

Sponsor: South Valley UniversityEnrolling: 501 location
RECRUITINGNCT01706692

Swiss Dermatology Network of Targeted Therapies (SDNTT)

The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A,...

Sponsor: Swiss Dermatology Network for Targeted TherapiesEnrolling: 11216 locations
RECRUITINGPhase 2 / Phase 3NCT07295509

A Study of Picankibart in Patients With Active Psoriatic Arthritis

This is a multicenter, randomized, double-blind, placebo-controlled Phase II/III clinical trial evaluating the efficacy and safety of picankibart (IBI112) in patients with active...

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Enrolling: 2221 location

Showing 50 of 102 trials.Search all Psoriasis trials